February 19, 2021

Multicenter Evaluation of the PanbioTM COVID-19 Rapid Antigen-Detection Test for the Diagnosis of SARS-CoV-2 Infection

Category: Article Summary

Topic: Testing and Treatment

Keywords (Tags): antigen, testing

A prospective multi-center study conducted in Spain found that the PanbioTM COVID-19 Ag Rapid Test Device, which tests for SARS-CoV-2 using nasopharyngeal swabs, has an overall sensitivity of 91% and specificity of 99%. Among the 128 asymptomatic participants who had close contact with a COVID-19 patient, there was full concordance in the 31 (24%) who were positive by RT-PCR and in the 97 that were negative.

Merino et al. (Feb 2021). Multicenter Evaluation of the PanbioTM COVID-19 Rapid Antigen-Detection Test for the Diagnosis of SARS-CoV-2 Infection. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2021.02.001